Nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors are overexpressed in extramammary Paget's disease

Journal of Cutaneous Pathology

Volumn 37, Issue 11, 2010, Pages 1150-1154

  Qian, Yue ^a,b   Takeuchi, Satoshi ^a   Chen, Shan Juan ^a,b   Dugu, Long ^a   Tsuji, Gaku ^a   Xie, Lining ^a   Nakahara, Takeshi ^a   Moroi, Yoichi ^a   Tu, Ya Ting ^b   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PAGET SKIN DISEASE;

AGED; AGED, 80 AND OVER; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; PAGET DISEASE, EXTRAMAMMARY; RECEPTORS, NERVE GROWTH FACTOR;

EID: 77956831743     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01563.x     Document Type: Article

References (24)

1. Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000 53 : 742.
2. Chen SY, Takeuchi S, Moroi Y, et al. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease. Int J Dermatol 2008 47 : 562.
3. Liu H, Urabe K, Uchi H, et al. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease. J Cutan Pathol 2007 34 : 33.
4. Lin N, Uchi H, Moroi Y, et al. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease. J Dermatol Sci 2007 45 : 187.
5. Liu H, Moroi Y, Yasumoto S, et al. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease. Br J Dermatol 2006 155 : 586.
6. Chen SY, Moroi Y, Urabe K, et al. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease. Arch Dermatol Res 2008 300 : 195.
7. Liu HJ, Moroi Y, Masuda T, et al. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease. Br J Dermatol 2006 154 : 926.
8. Chen SY, Moroi Y, Urabe K, et al. Differential expression of two new members of the P53 family, P63 and P73, in extramammary Paget's disease. Exp Dermatol 2008 33 : 634.
9. Chen SY, Takeuchi S, Moroi Y, et al. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease. J Cutan Pathol 2009 36 : 402.
10. Botchkarev VA, Yaar M, Peters EM, et al. Neurotrophins in skin biology and pathology. J Invest Dermatol 2006 126 : 1719.
11. Davidson B, Lazarovici P, Ezersky A, et al. Expression levels of the NGF receptors TrKA and P75NTR in effusions and solid tumors of serous ovarian carcinoma patients. Clin Cancer Res 2001 7 : 3457.
12. Truzzi F, Marconi A, Lotti R, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol 2008 128 : 2031.
13. Renné C, Minner S, Küppers R, et al. Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines. Leuk Res 2008 32 : 163.
14. Geldof AA, Van Haarst EP, Newling DW. Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis 1998 1 : 236.
15. Zhu Z, Kleeff J, Kayed H, et al. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog 2002 35 : 138.
16. Yang ZF, Ho DW, Lam CT, et al. Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 2005 65 : 219.
17. Tokusashi Y, Asai K, Tamakawa S, et al. Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int J Cancer 2005 114 : 39.
18. Aoyama M, Asai K, Shishikura T, et al. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001 164 : 51.
19. Yang ZF, Ho DW, Lau CK, et al. Platelet activation during tumor development, the potential role of BDNF-TrkB autocrine loop. Biochem Biophys Res Commun 2006 346 : 981.
20. Dolle L, Yazidi-Belkaura EL, Adrianseen E, et al. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 2003 22 : 5592.
21. Zhu ZW, Friess H, Wang L, et al. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 2001 7 : 105.
22. Papatsoris AG, Liolitsa D, Deliveliotis C. Manipulation of the nerve growth factor network in prostate cancer. Expert Opin Investig Drugs 2007 16 : 303.
23. Perez-Pinera P, Hernandez T, García-Suárez O, et al. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol Cell Biochem 2007 295 : 19.
24. Peng CH, Huang CN, Hsu SP, Wang CJ. Penta-acetyl geniposide-induced apoptosis involving transcription of NGF/p75 via MAPK-mediated AP-1 activation in C6 glioma cells. Toxicology 2007 238 : 130.